Thibaud Durand
Directeur Général chez Najeti SL
Profil
Thibaud Durand is currently the Chief Executive Officer at Najeti SL.
He also holds director positions at Palau Pharma SA, The European Association for Bioindustries, and SpainCap.
Previously, he was the Second Deputy Chairman at Oryzon Genomics SA and a Director at Arc Holdings SAS, The Genetics Co., Inc., and Eco-Solution SA. Durand holds an MBA from Instituto de Empresa SL and an undergraduate degree from Ecole Supérieure de Commerce de Reims.
Postes actifs de Thibaud Durand
| Sociétés | Poste | Début |
|---|---|---|
Najeti SL
 Najeti SL Investment ManagersFinance Najeti SL (Najeti) is the Spanish venture capital arm of Najeti SAS in France, founded in 1994 by Thibaud Durand. The firm headquartered in Madrid, Spain with addition offices in France and the US. | Directeur Général | 01/01/2000 |
SpainCap
 SpainCap Miscellaneous Commercial ServicesCommercial Services SpainCap operates as a non-profit organization. | Directeur/Membre du Conseil | - |
Palau Pharma SA
 Palau Pharma SA BiotechnologyHealth Technology Palau Pharma SA is a holding company engaged in the discovery and development of biophamaceuticals for the treatment of inflammatory and autoimmune diseases, such as rheumatoid arthritis, neuropathic pain, and chronic obstructive pulmonary disease. The company was founded on March 13, 1991 and is headquartered in Palau Solita i Plegamans, Spain. | Directeur/Membre du Conseil | - |
| The European Association for Bioindustries | Directeur/Membre du Conseil | - |
Anciens postes connus de Thibaud Durand
| Sociétés | Poste | Fin |
|---|---|---|
Eco-Solution SA
 Eco-Solution SA Miscellaneous Commercial ServicesCommercial Services Eco-Solution SA provides a platform that develops microorganisms for industrial environmental and regulatory requirements. Its directed in vivo evolution platform is based on the acceleration of natural evolution and requires no manipulation of the genome. Its bioconversion units developed by Eco-Solution employ advanced genetics and microorganisms to permit on-site disposal of hazardous industrial waste that is usually sent to incineration centers. The company was founded in 1999 and is headquartered in Romainville, France. | Directeur/Membre du Conseil | 20/07/2013 |
The Genetics Co., Inc.
 The Genetics Co., Inc. Medical/Nursing ServicesHealth Services The Genetics Company is a privately held drug discovery and development company active in the areas of cancer and neurodegenerative diseases. The company has identified small molecule inhibitors of two proprietary targets with in the Wnt-pathway, which is believed to play a crucial role in colon cancer. It has also identified small molecule inhibitors of BACE (beta-amyloid converting enzyme). In parallel, the company has identified and is in the process of further characterizing a series of novel growth-related drug target candidate genes for exploitation in cancer therapy. Headquartered in Zurich-Schlieren, Switzerland, the company currently has 29 employees. The Genetics Company offers you a range of high quality products to analyze Amyloid beta peptides x-40 and x-42 for basic research but also for pre-clinical and clinical development and in vitro diagnostics (IVD). Its CE-certified ELISA kits are the only clinically validated products for the determination of the Abeta42/40-Ratio in human CSF. These kits enable the early diagnosis of incipient Alzheimer's disease and can be used for patient stratification and monitoring in clinical trials of Alzheimer drug candidates. | Directeur/Membre du Conseil | - |
Arc Holdings SAS
 Arc Holdings SAS Home FurnishingsConsumer Durables Arc Holdings SAS manufactures and distributes tableware products. Its products include plates, cutlery, cookware, dishes, glasses and other dining materials. The firm distributes products through different distributors and outlet stores. The company was founded in 1825 and is headquartered in Arques, France. | Directeur/Membre du Conseil | - |
| ORYZON GENOMICS S.A. | Directeur/Membre du Conseil | - |
Formation de Thibaud Durand
| Ecole Supérieure de Commerce de Reims | Undergraduate Degree |
| Instituto de Empresa SL | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| ORYZON GENOMICS S.A. | Health Technology |
| Entreprise privées | 7 |
|---|---|
Najeti SL
Najeti SL Investment ManagersFinance Najeti SL (Najeti) is the Spanish venture capital arm of Najeti SAS in France, founded in 1994 by Thibaud Durand. The firm headquartered in Madrid, Spain with addition offices in France and the US. | Finance |
Eco-Solution SA
Eco-Solution SA Miscellaneous Commercial ServicesCommercial Services Eco-Solution SA provides a platform that develops microorganisms for industrial environmental and regulatory requirements. Its directed in vivo evolution platform is based on the acceleration of natural evolution and requires no manipulation of the genome. Its bioconversion units developed by Eco-Solution employ advanced genetics and microorganisms to permit on-site disposal of hazardous industrial waste that is usually sent to incineration centers. The company was founded in 1999 and is headquartered in Romainville, France. | Commercial Services |
Arc Holdings SAS
Arc Holdings SAS Home FurnishingsConsumer Durables Arc Holdings SAS manufactures and distributes tableware products. Its products include plates, cutlery, cookware, dishes, glasses and other dining materials. The firm distributes products through different distributors and outlet stores. The company was founded in 1825 and is headquartered in Arques, France. | Consumer Durables |
SpainCap
SpainCap Miscellaneous Commercial ServicesCommercial Services SpainCap operates as a non-profit organization. | Commercial Services |
Palau Pharma SA
Palau Pharma SA BiotechnologyHealth Technology Palau Pharma SA is a holding company engaged in the discovery and development of biophamaceuticals for the treatment of inflammatory and autoimmune diseases, such as rheumatoid arthritis, neuropathic pain, and chronic obstructive pulmonary disease. The company was founded on March 13, 1991 and is headquartered in Palau Solita i Plegamans, Spain. | Health Technology |
The Genetics Co., Inc.
The Genetics Co., Inc. Medical/Nursing ServicesHealth Services The Genetics Company is a privately held drug discovery and development company active in the areas of cancer and neurodegenerative diseases. The company has identified small molecule inhibitors of two proprietary targets with in the Wnt-pathway, which is believed to play a crucial role in colon cancer. It has also identified small molecule inhibitors of BACE (beta-amyloid converting enzyme). In parallel, the company has identified and is in the process of further characterizing a series of novel growth-related drug target candidate genes for exploitation in cancer therapy. Headquartered in Zurich-Schlieren, Switzerland, the company currently has 29 employees. The Genetics Company offers you a range of high quality products to analyze Amyloid beta peptides x-40 and x-42 for basic research but also for pre-clinical and clinical development and in vitro diagnostics (IVD). Its CE-certified ELISA kits are the only clinically validated products for the determination of the Abeta42/40-Ratio in human CSF. These kits enable the early diagnosis of incipient Alzheimer's disease and can be used for patient stratification and monitoring in clinical trials of Alzheimer drug candidates. | Health Services |
| The European Association for Bioindustries |
